Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

The European Respiratory Journal
Sergey E BorisovGiovanni Battista Migliori

Abstract

Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and effectiveness of bedaquiline-containing regimens in a large, retrospective, observational study conducted in 25 centres and 15 countries in five continents.428 culture-confirmed MDR-TB cases were analysed (61.5% male; 22.1% HIV-positive, 45.6% XDR-TB). MDR-TB cases were admitted to hospital for a median (interquartile range (IQR)) 179 (92-280) days and exposed to bedaquiline for 168 (86-180) days. Treatment regimens included, among others, linezolid, moxifloxacin, clofazimine and carbapenems (82.0%, 58.4%, 52.6% and 15.3% of cases, respectively).Sputum smear and culture conversion rates in MDR-TB cases were 63.6% and 30.1%, respectively at 30 days, 81.1% and 56.7%, respectively at 60 days; 85.5% and 80.5%, respectively at 90 days and 88.7% and 91.2%, respectively at the end of treatment. The median (IQR) time to smear and culture conversion was 34 (30-60) days and 60 (33-90) days. Out of 247 culture-confirmed MDR-TB cases completing treatment, 71.3% achieved success (62.4% cured; 8.9% completed treatment), 13.4% died, 7.3% defaulted and 7.7% failed. B...Continue Reading

References

Jun 6, 2009·The New England Journal of Medicine·Andreas H DiaconDavid F Mc Neeley
May 6, 2010·American Journal of Respiratory and Critical Care Medicine·Armand Van DeunHans L Rieder
Apr 13, 2012·The European Respiratory Journal·Giovanni SotgiuGiovanni Battista Migliori
Jun 8, 2012·The New England Journal of Medicine·Maria Tarcela GlerCharles D Wells
Sep 29, 2012·The European Respiratory Journal·Vija SkripconokaCharles D Wells
Oct 13, 2012·The European Respiratory Journal·G B MiglioriUNKNOWN “The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB”
Oct 19, 2012·The New England Journal of Medicine·Myungsun LeeClifton E Barry
Jul 3, 2013·The European Respiratory Journal·Giovanni SotgiuUNKNOWN International Group for the study of Linezolid
Aug 21, 2013·The European Respiratory Journal·Roland DielAlbert Nienhaus
Aug 31, 2013·The European Respiratory Journal·Simon TiberiGiovanni Battista Migliori
Aug 31, 2013·The European Respiratory Journal·Noor AlsaadJan-Willem C Alffenaar
Aug 21, 2014·The New England Journal of Medicine·Andreas H DiaconUNKNOWN TMC207-C208 Study Group
Sep 23, 2014·The European Respiratory Journal·Shenjie TangZhanjun Zhang
Oct 10, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·Z F UdwadiaJ B Mullerpattan
Oct 17, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lorenzo GuglielmettiUNKNOWN MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Coh
Jan 2, 2015·The European Respiratory Journal·Giovanni SotgiuGiovanni Battista Migliori
Jan 2, 2015·The European Respiratory Journal·Giovanni SotgiuGiovanni Battista Migliori
Jan 22, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shenjie TangZhanjun Zhang
Mar 21, 2015·The European Respiratory Journal·Knut LönnrothMario C Raviglione
Jul 15, 2015·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·N NdjekaY Pillay
Jul 16, 2015·The New England Journal of Medicine·Myungsun LeeIna Jeong
Sep 19, 2015·The European Respiratory Journal·Nicholas WintersDick Menzies
Nov 7, 2015·The European Respiratory Journal·Simon TiberiGiovanni Battista Migliori
Nov 21, 2015·The European Respiratory Journal·Simon TiberiGiovanni Battista Migliori
Dec 10, 2015·The European Respiratory Journal·Alexander S PymUNKNOWN TMC207-C209 Study Group
Jan 9, 2016·The European Respiratory Journal·Sander P van RijnJan-Willem C Alffenaar
Feb 2, 2016·The European Respiratory Journal·Emanuele PontaliGiovanni Battista Migliori
Feb 26, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Simon TiberiGiovanni Battista Migliori
Mar 12, 2016·The European Respiratory Journal·Simon TiberiGiovanni Battista Migliori
Jun 12, 2016·The European Respiratory Journal·Marina TadoliniGiovanni Battista Migliori
Nov 2, 2016·The European Respiratory Journal·Adrian RendonGiovanni Battista Migliori
Nov 2, 2016·The European Respiratory Journal·Marina TadoliniGiovanni Battista Migliori
Feb 10, 2017·The European Respiratory Journal·Lorenzo GuglielmettiUNKNOWN French MDR-TB Management Group
Mar 24, 2017·The European Respiratory Journal·Dennis FalzonKarin Weyer
Mar 24, 2017·The European Respiratory Journal·Margareth DalcolmoGiovanni B Migliori
Mar 24, 2017·The European Respiratory Journal·Emanuele PontaliGiovanni Battista Migliori
Apr 14, 2017·The European Respiratory Journal·Margareth DalcolmoGiovanni Battista Migliori

❮ Previous
Next ❯

Citations

Feb 23, 2018·Current Opinion in Pulmonary Medicine·Emanuele PontaliGiovanni Battista Migliori
Apr 12, 2018·Respirology : Official Journal of the Asian Pacific Society of Respirology·Christoph LangeKeertan Dheda
Aug 4, 2018·Expert Review of Pharmacoeconomics & Outcomes Research·Ana-Maria IonescuAdrian Thomas
Mar 2, 2018·Current Treatment Options in Neurology·Angharad DavisRobert J Wilkinson
May 5, 2018·The European Respiratory Journal·Erika MohrPetros Isaakidis
Jul 22, 2017·The European Respiratory Journal·Lorenzo GuglielmettiCarole D Mitnick
Jun 9, 2018·The European Respiratory Journal·Lorenzo GuglielmettiUNKNOWN of the TBnet QTc survey
Dec 30, 2017·The European Respiratory Journal·Andrea Maurizio CabibbeGiovanni Battista Migliori
Apr 22, 2018·The European Respiratory Journal·Giovanni Battista MiglioriMarieke J van der Werf
Jul 7, 2017·The European Respiratory Journal·Jose A CamineroGiovanni Battista Migliori
Mar 24, 2018·The European Respiratory Journal·Tiziana MasiniErnesto Jaramillo
Nov 11, 2017·The European Respiratory Journal·Jose A CamineroGiovanni Battista Migliori
Nov 18, 2017·The European Respiratory Journal·Emanuele PontaliGiovanni B Migliori
Oct 6, 2018·The European Respiratory Journal·Neel R GandhiN Sarita Shah
May 23, 2017·The European Respiratory Journal·Lorenzo Guglielmetti
Jun 15, 2018·European Respiratory Review : an Official Journal of the European Respiratory Society·Alberto MatteelliGiovanni Battista Migliori
Jun 16, 2018·The European Respiratory Journal·Emanuele PontaliGiovanni Battista Migliori
Mar 21, 2019·The Cochrane Database of Systematic Reviews·Bhagteshwar SinghDerek J Sloan
Mar 23, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mathieu BastardAlex Telnov
May 1, 2019·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Simon TiberiGiovanni Battista Migliori
May 1, 2019·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Giovanni Battista MiglioriAdrian Rendon
Jul 25, 2019·Expert Opinion on Drug Safety·Karen Cohen, Gary Maartens
May 18, 2019·The European Respiratory Journal·Irina VasilyevaUNKNOWN TMC207TBC3001 study group
Jul 3, 2019·Antimicrobial Agents and Chemotherapy·Arash GhodousiDaniela Maria Cirillo
Nov 16, 2019·American Journal of Respiratory and Critical Care Medicine·Payam NahidBarbara Seaworth
Nov 9, 2019·The European Respiratory Journal·Jan-Willem C AlffenaarUNKNOWN Global Tuberculosis Network Bedaquiline study group
Feb 16, 2020·The European Respiratory Journal·Camus NimmoMax O'Donnell
Jan 4, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Hao ChenXiaohui Huang
Jul 24, 2020·Future Microbiology·Lorenzo GuglielmettiJérôme Robert
Jul 15, 2020·Antimicrobial Agents and Chemotherapy·Nazir Ahmed IsmailShaheed V Omar
May 21, 2020·The European Respiratory Journal·Fatma KortNicolas Veziris
Aug 9, 2017·Expert Opinion on Pharmacotherapy·Malaisamy Muniyandi, Rajeswari Ramachandran
Apr 6, 2019·Open Forum Infectious Diseases·Eun Hye LeeYoung Ae Kang
May 31, 2019·European Respiratory Review : an Official Journal of the European Respiratory Society·Emanuele PontaliUNKNOWN and the writing group members of the Global TB Network Clinical Trials Committee
Sep 13, 2020·Current HIV/AIDS Reports·Elisa H Ignatius, Susan Swindells
May 24, 2018·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Denise Rossato SilvaGiovanni Battista Migliori
Jun 24, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Elena PiniDaniela Barlocco
May 24, 2018·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Denise Rossato SilvaGiovanni Battista Migliori

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.